- Investing Ideas
- Japanese Pharmaceuticals & Biotech Undervalued Dividend Payers
Japanese Pharmaceuticals & Biotech Undervalued Dividend Payers
Results
8
Companies available at a discount paying at least a 2% dividend yield.
8 companies
Takeda Pharmaceutical
Market Cap: JP¥8.7t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.
4502
JP¥5,480.00
7D
2.3%
1Y
26.2%
Astellas Pharma
Market Cap: JP¥3.9t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,151.00
7D
0.4%
1Y
48.5%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,876.00
7D
1.5%
1Y
15.4%
Kyowa Kirin
Market Cap: JP¥1.4t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,654.50
7D
0.5%
1Y
5.2%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,425.50
7D
-0.1%
1Y
51.6%
Santen Pharmaceutical
Market Cap: JP¥657.0b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥2,042.50
7D
-4.3%
1Y
21.7%
Tsumura
Market Cap: JP¥287.0b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,850.00
7D
0.8%
1Y
6.0%
Kissei Pharmaceutical
Market Cap: JP¥172.6b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,165.00
7D
1.6%
1Y
-1.3%